These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Hambrecht M, Häfner H. Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971 [Abstract] [Full Text] [Related]
6. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH. Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725 [Abstract] [Full Text] [Related]
7. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T, Liraud F, Verdoux H. Encephale; 2003 Mar; 29(5):430-7. PubMed ID: 14615692 [Abstract] [Full Text] [Related]
8. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B. Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495 [Abstract] [Full Text] [Related]
10. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Jockers-Scherübl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gómez-Carrillo de Castro A, Kühl KP. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1054-63. PubMed ID: 17482741 [Abstract] [Full Text] [Related]
17. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Dekker N, Smeerdijk AM, Wiers RW, Duits JH, van Gelder G, Houben K, Schippers G, Linszen DH, de Haan L. Psychol Med; 2010 Aug 30; 40(8):1325-36. PubMed ID: 19917142 [Abstract] [Full Text] [Related]